Stay informed and updated with the AMA
COVID-19 news & events
—The Centers for Disease Control and Prevention (CDC) releases a new Health Alert Network (HAN) Health Advisory on Using Therapeutics to Prevent and Treat COVID-19.
—The U.S. Food and Drug Administration (FDA) issues an emergency use authorization (EUA) for Merck’s molnupiravir for the treatment of mild-to-moderate COVID-19 in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19.
—FDA releases a health care providers fact sheet that includes dosing instructions, potential side effects and information about who is able to prescribe molnupiravir.
—FDA issues an emergency use authorization (EUA) for Pfizer’s Paxlovid for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients with positive results of direct SARS-CoV-2 testing and who are at high risk for progression to severe COVID-19.
—FDA releases a new fact sheet on Paxlovid for health care providers: Emergency User Authorization for Paxlovid.
COVID-19 news, press and daily video collections
—Follow the AMA news coverage on COVID-19
—Read the latest AMA COVID-19 press releases
—Watch the AMA COVID-19 video updates